DIAMEDICA THERAPEUTICS INC.
Profile
Company Names
DIAMEDICA THERAPEUTICS INC.
Addresses
301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN 55305
TWO CARLSON PARKWAY, SUITE 260, MINNEAPOLIS, MN 55447
2 CARLSON PARKWAY, SUITE 260, MINNEAPOLIS, MN 55447
Phone Numbers
(763) 312-6755
(763) 496-5454
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
CANADA (FEDERAL LEVEL)
Total Amount Raised:
$110,387,718.00
Number of Funding Rounds:
6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2025-07-23
$30,100,000.00
$30,100,000.00
$0.00
Equity
5
2024-06-28
$11,800,000.00
$11,800,000.00
$0.00
Equity
4
2023-06-23
$37,536,853.00
$37,536,853.00
$0.00
Equity
3
2023-04-10
$750,000.00
$750,000.00
$0.00
Equity
2
2021-09-28
$29,999,995.00
$29,999,995.00
$0.00
Equity
1
2018-03-29
$200,870.00
$344,348.00
$143,478.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
SCOTT
KELLEN
EXECUTIVE OFFICER
RICHARD
KUNTZ
DIRECTOR
DANIEL
O-CONNOR
DIRECTOR
JAMES
PARSONS
DIRECTOR
RICK
PAULS
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2025-07-23
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-06-28
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-06-23
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-04-10
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-09-28
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-03-29
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

